HPV16 E7 (86-93)
This peptide corresponds to residues 86-93 of the HPV16 E7 oncoprotein, exhibiting high-affinity binding to HLA-A*0201. It serves as a critical research tool for developing therapeutic vaccines against cervical carcinoma, with applications in both in vitro immunogenicity assays and in vivo preclinical vaccine studies.
Product Specifications
Field of Research
Infectious Disease & Virology
Molecular Weight
815.03
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
